[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Preliminary Program for Sixth International Radiopharmaceutical

The following is being posted at the request of Mike Stabin
<STABINM@ORAU.GOV>.  He does not subscribe to radsafe, so please send
inquiries to his direct e-mail address.

Dave Scherer
scherer@uiuc.edu
>---------------------------------------------------------------------------
----------
>
>
>Listed below is the preliminary program for the Sixth International
>Radiopharmaceutical Dosimetry Symposium, to be held on May 7-10,
>1996 in Gatlinburg, TN, USA.  Please contact Ms. Audrey Stelson at
>423-576-3450, or stelsona@orau.gov for further information.
>
>
>Preliminary Program (presenting authors)
>
>QUANTITATIVE ANALYSIS and TREATMENT PLANNING
>
>Invited Paper: Internal Dosimetry, Where Are We Going?		S.
>Mattsson, Lund Univ.
>Invited Paper: Treatment Planning for Internal Emitter Therapy	G.
>Sgouros, Sloan-Kettering 
>Parameters for Treatment Planning with SPECT			M.
>Ljungberg, Lund Univ.
>SPECT-Based Dosimetry Method for Activity Quantitation		R.
>Dunn, Garden State Cancer Ctr
>Patient Specific Dosimetry Based on SPECT & 3-D DFT		G.
>Akabani, Univ. Nebraska 
>3-D DVH Analysis for Bremsstrahlung SPECT			E.
>Parsai, Medical College of Ohio
>SPECT in the Calculation of Dosage for Thyroid Therapy		S.
>Muller, Netherlands Cancer Inst
>Simplifications for Dosimetric Models for RIT			S.
>Shen, Univ. Calif. at Davis
>Dosimetry of $+ Radiopharmaceuticals based on PET		C.
>Brihaye, LiŠge Univ.
>Quantitative Whole-Body Kinetics of  86Y with PET			F.
>R”sch, KFA Jlich 
>Marrow Suppression & Absorbed Dose 117mSn DTPA		J.
>Stubbs, Dosimetry Systems 
>Hematologic Toxicity in RIT with 131I NP-4IgG1			T. Behr,
>Garden State Cancer Ctr
>Kinetics & Dosimetry after Repeated 111In Octreotide		E.
>Forssell-Aronsson, G”teborg Univ 
>Whole-Body Dosimetry & Therapy of  METS with 131I		J.
>Kopp, Nucl Med Clinic Augsberg   
>Absorbed Dose to Nontarget Tissue at 131I Treatment		H.
>J”nsson, Malm” Univ.
>Model for Dosimetry of Intralesional Radionuclide Therapy		G. Flux,
>Royal Marsden Hosp., UK
>Dose Estimates from Intraperitoneal 177Lu CC49			R.
>Meredith, Univ. Alabama
>
>CELLULAR and SMALL SCALE DOSIMETRY
>
>Invited Paper: Current Status of Microdosimetry			J.
>Humm, Sloan-Kettering
>Dose Calculations for Low-Energy Electron Emitters		C.
>Hindorf, Lund Univ.
>Cellular Dosimetry of 99mTc, 123I, 111In, 67Ga &
>201Tl			I. Gardin, Beaujon Hosp., Paris
>Cellular Uptake of 212Bi OCl: A Dosimetric
>Analysis			J. Roeske, Univ. Chicago
>Effects of  Lymphocyte Irradiation: 99mTc HMPAO WBC		C. De
>Labriolle-Vaylet, Paris
>Morphology of Lung Cells after 99mTc
>Microspheres			M. Robinson, Facult‚ X. Bichat
>Factors Influencing Tumor Dosimetry in RIT with 131I MAbs	T. Behr,
>Garden State Cancer Ctr
>Dosimetry for Intratumoral Injection of 201Tl in Radiotherapy	S.-E.
>Strand, Lund Univ.
>3-D Tumor Dose Distributions for CC49 & 17-1A MAbs		P.
>Roberson, Univ. Michigan
>90Y Dosimetry in Mice: Evaluation of Three Models			T. Behr,
>Garden State Cancer Ctr
>Testicular Toxicity of 111In oxine, -chloride & X-rays		B.-A.
>J”nsson, Lund Univ. 
>Ovarian Dose in Radium Dial Painters -Dosimetric Methods	J. Roeske,
>Univ. Chicago
>Small Scale Dosimetry of Bone & Marrow for 89Sr & 90Y		G.
>Akabani, Univ. Nebraska
>S-Values for Suborgan Dosimetry for Nonuniform Distribution	W.
>Bolch, Univ. Florida
>Absorbed Fractions & S-Values for Subregions in the
>Brain		M. Tagesson, Lund Univ.
>High Resolution, MRI-Based, Segmented Head Phantom		I. Zubal,
>Yale Univ.
>
>DOSIMETRIC MODELS
>
>Invited Paper: Work of the ICRP Dosimetry Task Group		K.
>Eckerman, Oak Ridge Natl Lab
>Model Developments in Macrodosimetry				A.
>Phipps, NRPB
>Propriety of ICRP GI Tract Model for 201Tl Dosimetry		K.
>Lathrop, Univ. Chicago
>A New Blood Circulation Model for Reference Man		K. Eckerman,
>Oak Ridge Natl Lab 
>New Dosimetric Model for Spine & CSF in Intrathecal Injection	M.
>Stabin, ORISE
>Absorbed Dose in Salivary Glands from 99mTc
>Complexes		L. Johansson, Ume† Univ.
>Extravasation of Radiopharmaceuticals: Dosimetric
>Considerations	S.-E. Strand, Lund Univ.
>Analysis of Dosimetry Parameters for Nuclear Medicine                  R.
>Toohey, ORISE
>Effect of Wr,Auger>1 for Radiopharmaceuticals on Equivalent
>Dose	A. Wright, Amersham UK
>Neural Networks for Kinetic Model Parameter Estimation in PET	N.
>Narayana, Univ. Tennessee
>
>RADIOPHARMACEUTICAL KINETICS AND DOSIMETRY
>
>Invited Paper: Design and Analysis of Tracer Kinetic Studies*	D.
>Foster, SAAM Inst.
>Dose Estimates for Radiolabeled Antibodies and
>Fragments		A. Green, CRC Labs London
>Comparison of Clinical Data with a Model of  MAb Distribution	C.
>Johnson, CRC Labs London
>Pharmacokinetic Comparison of Two Forms of 99mTc Oncospect	G.
>Mardirossian, Univ. Mass.
>Absorbed Dose Estimates for 14C-Labeled
>Pharmaceuticals		S. Mattsson, Lund Univ.
>Dose Estimates for a Capsule-based 14C Urea Breath
>Test		M. Combs, Tri?Med Specialities 
>Radiation Absorbed Dose to Patients from 111In CYT-356		A. Brill,
>Univ. Mass.
>In-Vivo Distribution & Dosimetry of 111In Octreotide in Man	S.
>Leide-Svegborn, Malm” Univ.
>111In Octreotide Kinetics in Neuroendocrine Tumor
>Patients		E. Forssell-Aronsson, G”teborg Univ
>99mTc DMSA in Children: Biodistribution & Dosimetry		T.
>Smith, Great Ormond St. Hosp.
>Biokinetic Model for 137Cs  in the Fetus				K.
>Jones, Georgia Inst. Tech.
>Radiopharmaceutical Placental Transfer & Dosimetry in
>Pregnancy	J. Russell, ORISE 
>
>DATA EXTRAPOLATION
>
>Animal Data Scaling Techniques in Estimating Human Dose	R.
>Sparks, ORISE
>Dosimetry of 99mTc SESTAMIBI:  Rat Data Compared to Human	L.
>J”nsson, Lund Univ.
>Kinetics of 111In Radiopharmaceuticals in Animal and Man		B.-A.
>J”nsson, Lund Univ. 
>Radiation Dose Estimates in Animals for DMP-444			J.
>Lazewatsky, DuPont Merck
>Uncertainty Analysis for 123I IPT, a Receptor Imaging Agent	B.
>Aydogan, Univ. Tennessee
>Bayesian Methods for Biokinetic Models				P.
>Groer, Univ. Tennessee
>
>EVENING SESSION
>
>Radiopharmaceutical Binding on Blood Elements			R.
>Freitas, Inst. Nacional de Cancer
>Monte Carlo Calculation of Auger Emissions from 157Gd (n,()      	C-K
>Wang, Georgia Inst. Tech.
>Effect of Labeling Isotope on MAb Dosimetry in Mice		C.
>Kwok, Hamilton Reg. Cancer Ctr.
>131I NaI Fetal Dosimetry for Post-administration Conception	R.
>Sparks, ORISE
>Marrow Cell Effects Modeled by the MarCell Code*		T. Jones, Oak
>Ridge Natl. Lab.
>Effective Dose for Indian Adults from 3H Water & 131I NaI		S. Jain,
>Inst. Nucl. Medicine Delhi
>Dosimetry of 223Radium & Progeny 					D.
>Fisher, Battelle Northwest
>Macro-& Microdosimetry for BNCT with MOSFET Probe		A.
>Rosenfeld, Univ. Wollongong
>Dosimetry of BNCT Using MOSFET & Pin Diodes			M.
>Carolan, Univ. Wollongong
>Mini-TLD Dose Measurements for In-Vivo Use			M.
>Strandh, Lund Univ.
>SIMDOS Code for Dose & Dose Rate Distributions			M.
>Tagesson, Lund Univ.
>MABDOSE: Program for the Calculation of Internal Dose		T.
>Johnson, Univ. Colorado
>Some Issues in the Use of the Remainder of the Body Correction	M.
>Stabin, ORISE
>Effect of Scatter Subtraction on SPECT Quantitation		W.
>Dunn, Mayo Clinic
>
>*Software will be demonstrated
>